In The News Posted March 22, 2019 Share Posted March 22, 2019 OXFORD, England, March 22, 2019 /PRNewswire/ -- Evox Therapeutics Ltd ('Evox' or the 'Company'), a leading exosome therapeutics company, today announces that it has secured £1.5 million in funding from Innovate UK, the UK's Innovation Agency, through the Biomedical Catalyst Early Stage... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.